Data / Drug companies / Estrogen
Estrogen drugs: 34 drugs from 84 companies in the FDA NDC directory
Estrogen is an FDA established pharmacologic class. The FDA National Drug Code Directory lists 399 products in this class from 84 companies, covering 34 drugs by generic name. The main marketing category is generic drugs (ANDA), and the newest product started marketing on October 1, 2026.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- 84Companies
- 399Products
- 34Drugs by generic name
Drugs in the Estrogen class
Ranked by number of companies that list the drug.
| Drug | Products here | Companies listing it |
|---|---|---|
| Estradiol | 250 | 53 |
| Levonorgestrel and ethinyl estradiol | 3 | 19 |
| Norethindrone and ethinyl estradiol | 1 | 12 |
| Norethindrone acetate and ethinyl estradiol | 19 | 10 |
| Norelgestromin and ethinyl estradiol | 8 | 8 |
| Estradiol and norethindrone acetate | 12 | 7 |
| Etonogestrel and ethinyl estradiol | 8 | 6 |
| Estrogens, conjugated | 17 | 4 |
| Estradiol valerate | 10 | 4 |
| Estradiol/norethindrone acetate | 6 | 2 |
| Conjugated estrogens/bazedoxifene | 2 | 2 |
| Etonogestrel and ethinyl estradiol vaginal | 2 | 2 |
| Estrogen | 1 | 2 |
| Estradiol gel 0.1% | 5 | 1 |
| Estradiol transdermal | 5 | 1 |
| Conjugated estrogens and medroxyprogesterone acetate | 4 | 1 |
| Estradiol acetate | 4 | 1 |
| Conjugated estrogens | 2 | 1 |
| Drospirenone and estradiol | 2 | 1 |
| Estradiol/norethindrone acetate transdermal system | 2 | 1 |
| Estriol,estradiol | 2 | 1 |
| Estradiol and levonorgestrel | 1 | 1 |
| Estradiol cypionate | 1 | 1 |
| Estradiol, | 1 | 1 |
| Estradiol, folliculinum, oophorinum (suis) | 1 | 1 |
| Estriol and estradiol cream | 1 | 1 |
| Estriol,estradiol,estrogen cream | 1 | 1 |
| Estriol,estradiol,progesterone,dhea | 1 | 1 |
| Etonogestrel and ethinyl estradiol vaginal ring | 1 | 1 |
| Junel fe | 1 | 1 |
| Levonorgestrel/ethinyl estradiol | 1 | 1 |
| Norelgestromin and ethinly estradiol | 1 | 1 |
| Relugolix, estradiol hemihydrate, and norethindrone acetate | 1 | 1 |
| Segesterone acetate and ethinyl estradiol | 1 | 1 |
Companies with the most products in this class
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| A-S Medication Solutions | 30 | tablet; patch | Generic drugs (ANDA) | May 19, 2025 |
| Amneal Pharmaceuticals NY LLC | 20 | patch, extended release; gel | Generic drugs (ANDA) | July 15, 2024 |
| Mylan Pharmaceuticals Inc. | 20 | patch; tablet | Generic drugs (ANDA) | September 25, 2019 |
| Amneal Pharmaceuticals LLC | 13 | patch, extended release; ring | Generic drugs (ANDA) | September 30, 2020 |
| Xiromed, LLC | 13 | gel; tablet | Generic drugs (ANDA) | January 29, 2025 |
| Zydus Lifesciences Limited | 13 | patch; patch, extended release | Generic drugs (ANDA) | November 21, 2023 |
| Noven Therapeutics, LLC | 12 | film, extended release; patch, extended release | New drug applications (NDA) | January 1, 2018 |
| Bryant Ranch Prepack | 11 | patch, extended release; gel | Generic drugs (ANDA) | December 7, 2023 |
| Sandoz Inc | 11 | patch; patch, extended release | Authorized generics (NDA) | December 22, 2014 |
| Wyeth Pharmaceuticals LLC, a Subsidiary of Pfizer Inc. | 11 | tablet, film coated; tablet, sugar coated | New drug applications (NDA) | December 3, 2012 |
| Bayer HealthCare Pharmaceuticals Inc. | 10 | patch; tablet, film coated | New drug applications (NDA) | February 29, 2012 |
| Ani Pharmaceuticals, Inc. | 9 | gel; tablet | Generic drugs (ANDA) | October 23, 2024 |
| Bryant Ranch Prepack | 9 | tablet; cream | Generic drugs (ANDA) | September 6, 2023 |
| NorthStar RxLLC | 9 | gel; tablet | Generic drugs (ANDA) | September 1, 2025 |
| Ingenus Pharmaceuticals, LLC | 8 | tablet, film coated; tablet | Generic drugs (ANDA) | October 16, 2025 |
| Encube Ethicals, Inc. | 7 | gel; cream | Generic drugs (ANDA) | May 13, 2026 |
| NuCare Pharmaceuticals,Inc. | 7 | tablet; cream | Generic drugs (ANDA) | September 6, 2023 |
| Prasco Laboratories | 7 | tablet, film coated; insert, extended release | Authorized generics (NDA) | February 27, 2026 |
| Zydus Pharmaceuticals USA Inc. | 7 | patch | Generic drugs (ANDA) | November 2, 2023 |
| Asclemed USA, Inc. | 6 | tablet | Generic drugs (ANDA) | April 10, 2017 |
| Bryant Ranch Prepack | 6 | insert; tablet | Generic drugs (ANDA) | January 6, 2021 |
| Deseret Biologicals, Inc. | 6 | liquid; tablet | Unapproved homeopathic products | February 19, 2026 |
| Glenmark Pharmaceuticals Inc., USA | 6 | tablet; tablet, film coated | Generic drugs (ANDA) | September 17, 2018 |
| Padagis Israel Pharmaceuticals Ltd | 6 | gel; cream | Generic drugs (ANDA) | December 7, 2023 |
| Professional Complementary Health Formulas | 6 | liquid | Unapproved homeopathic products | August 15, 1984 |
| Teva Pharmaceuticals USA, Inc. | 6 | tablet | Generic drugs (ANDA) | September 18, 2003 |
| Zydus Pharmaceuticals USA Inc. | 6 | patch, extended release; patch | Generic drugs (ANDA) | November 21, 2023 |
| Remedyrepack Inc. | 5 | tablet | Generic drugs (ANDA) | November 22, 2023 |
| Sandoz Inc | 5 | patch, extended release | New drug applications (NDA) | January 8, 1999 |
| Teva Pharmaceuticals USA, Inc. | 5 | tablet; insert | Generic drugs (ANDA) | January 19, 2021 |
| Trigen Laboratories, LLC | 5 | gel | New drug applications (NDA) | October 10, 2022 |
| Vertical Pharmaceuticals, LLC | 5 | gel | New drug applications (NDA) | December 17, 2019 |
| AvKARE | 4 | ring; tablet | Generic drugs (ANDA) | September 21, 2023 |
| BioActive Nutritional, Inc. | 4 | liquid | Unapproved homeopathic products | January 3, 2025 |
| Direct_Rx | 4 | tablet | Generic drugs (ANDA) | January 8, 2026 |
| Millicent US, Inc. | 4 | ring | New drug applications (NDA) | August 1, 2026 |
| Nutritional Specialties, Inc. | 4 | liquid; spray | Unapproved homeopathic products | September 25, 2024 |
| Shyne Brands | 4 | cream | Other unapproved drugs | June 1, 2025 |
| Aurobindo Pharma Limited | 3 | tablet, film coated | Generic drugs (ANDA) | August 2, 2024 |
| Energique, Inc. | 3 | liquid | Unapproved homeopathic products | March 1, 2022 |
| Epic Pharma, LLC | 3 | tablet | Generic drugs (ANDA) | April 10, 2017 |
| Hikma Pharmaceuticals USA Inc. | 3 | injection | Generic drugs (ANDA) | April 21, 2020 |
| Northwind Health Company, LLC | 3 | tablet | Generic drugs (ANDA) | February 15, 2023 |
| PD-Rx Pharmaceuticals, Inc. | 3 | tablet | Generic drugs (ANDA) | September 6, 2023 |
| Preferred Pharmaceuticals Inc. | 3 | tablet | Generic drugs (ANDA) | April 11, 2025 |
| Puracap Laboratories LLC DBA Blu Pharmaceuticals | 3 | tablet | Generic drugs (ANDA) | September 10, 2021 |
| Redpharm Drug | 3 | cream; tablet | Generic drugs (ANDA) | August 14, 2025 |
| American Regent, Inc. | 2 | injection, solution | Generic drugs (ANDA) | March 1, 2020 |
| Amneal Pharmaceuticals LLC | 2 | tablet, film coated | New drug applications (NDA) | May 1, 2019 |
| Aurobindo Pharma Limited | 2 | tablet | Generic drugs (ANDA) | June 26, 2017 |
| Breckenridge Pharmaceutical, Inc. | 2 | tablet, film coated | Generic drugs (ANDA) | June 9, 2011 |
| Lupin Pharmaceuticals, Inc. | 2 | tablet, film coated | Generic drugs (ANDA) | March 15, 2016 |
| Northwind Health Company, LLC | 2 | tablet | Generic drugs (ANDA) | January 18, 2024 |
| Par Health USA, LLC | 2 | injection | New drug applications (NDA) | November 1, 2007 |
| PharmPak, Inc. | 2 | tablet | Generic drugs (ANDA) | July 9, 2019 |
| ProBLEN | 2 | spray | Unapproved homeopathic products | December 22, 2025 |
| Proficient Rx LP | 2 | tablet | Generic drugs (ANDA) | September 6, 2023 |
| Teva Women's Health LLC | 2 | tablet | Generic drugs (ANDA) | February 26, 2015 |
| Advanz Pharma (US) Corp. | 1 | insert, extended release | New drug applications (NDA) | May 19, 2025 |
| Agile Therapeutics, Inc. | 1 | patch | New drug applications (NDA) | September 11, 2020 |
| Allergan, Inc. | 1 | cream | Generic drugs (ANDA) | July 1, 2001 |
| Alvogen Inc. | 1 | cream | Generic drugs (ANDA) | March 5, 2018 |
| American Health Packaging | 1 | tablet | Generic drugs (ANDA) | May 2, 2025 |
| Amneal Pharmaceuticals of New York LLC | 1 | insert | Generic drugs (ANDA) | June 7, 2015 |
| Ascend Therapeutics US, LLC | 1 | gel, metered | New drug applications (NDA) | February 9, 2004 |
| Coupler LLC | 1 | tablet | Generic drugs (ANDA) | June 17, 2025 |
| Guangzhou Shunfei Network Technology Co., Ltd. | 1 | cream | Over the counter monograph drugs | August 31, 2026 |
| Guna Spa | 1 | solution/ drops | Unapproved homeopathic products | May 23, 2006 |
| Mayne Pharma | 1 | ring | New drug applications (NDA) | August 16, 2024 |
| Naari Pte Limited | 1 | tablet | Generic drugs (ANDA) | June 11, 2024 |
| NorthStar Rx LLC | 1 | ring | Generic drugs (ANDA) | November 1, 2023 |
| Novo Nordisk | 1 | insert | New drug applications (NDA) | January 11, 2010 |
| Organon LLC | 1 | insert, extended release | New drug applications (NDA) | June 1, 2021 |
| Padagis US LLC | 1 | spray | New drug applications (NDA) | April 11, 2015 |
| Pfizer Laboratories Div Pfizer Inc | 1 | system | New drug applications (NDA) | June 5, 2023 |
| Pharmacia & Upjohn Company LLC | 1 | injection | Generic drugs (ANDA) | August 15, 1979 |
| Proficient Rx LP | 1 | tablet | Generic drugs (ANDA) | October 28, 1997 |
| Solaris Pharma Corporation | 1 | gel | Generic drugs (ANDA) | January 28, 2026 |
| Sumitomo Pharma America, Inc. | 1 | tablet, film coated | New drug applications (NDA) | May 26, 2021 |
| Teva Pharmaceuticals, Inc. | 1 | tablet | Generic drugs (ANDA) | March 1, 2023 |
| U.S. Pharmaceuticals | 1 | tablet, film coated | New drug applications (NDA) | November 15, 2013 |
| Viatris Specialty LLC | 1 | gel, metered | New drug applications (NDA) | June 2, 2014 |
| Viatris Specialty LLC | 1 | patch | New drug applications (NDA) | October 1, 2026 |
| Wyeth Pharmaceuticals LLC, a Subsidiary of Pfizer Inc. | 1 | tablet, film coated | New drug applications (NDA) | October 3, 2013 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet | 104 | 26.1% |
| Patch | 60 | 15% |
| Patch, extended release | 47 | 11.8% |
| Gel | 46 | 11.5% |
| Tablet, film coated | 39 | 9.8% |
| Cream | 26 | 6.5% |
| Liquid | 20 | 5% |
| Film, extended release | 11 | 2.8% |
| Ring | 9 | 2.3% |
| Injection | 9 | 2.3% |
| Insert, extended release | 7 | 1.8% |
| Insert | 5 | 1.3% |
Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.